Please join us for a day-long conference at Harvard Law School on September 18, 2014, which will include presentations by leading experts and varied stakeholders as well as small group discussion and break out sessions that will work toward developing consensus in this difficult area.
Key questions include:
- How should post-trial access be defined?
- What type of interventions should be included in post-trial access obligations?
- What are the responsibilities of various stakeholders?
More information, including the developing agenda, will be posted on the Petrie-Flom Center’s website as it becomes available.
Cosponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Multi-Regional Clinical Trials Center at Harvard University.